Laboratory Corporation of America Holdings (LH) , or Labcorp, is well-poised to grow in the coming quarters, led by collaborations with leading pharmaceutical and biotechnology companies. Labcorp also remains active on the acquisition front, maintaining a solid business development pipeline. However, adverse currency fluctuations are a concerning for the company. In the past year, this Zacks Rank #3 (Hold) stock has gained 6.3% compared with a 4.7% rise of the industry and a 27.8% increase of the S&P 500 co ...